MELODY Registry Follow-Up Study

University Hospital Tuebingen845 enrolled

Overview

Extension of the MELODY Registry, to assess longterm follow-up clinical results of Melody valve implantation after its commercialization in Europe / OUS

Study Type

OBSERVATIONAL

Enrollment

845

Conditions

Congenital Heart Disease (CHD)

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * previous inclusion in the MELODY Registry Exclusion Criteria: * none

Locations (1)

University Hospital Tübingen

Tübingen, Germany

RECRUITING

Outcomes

Primary Outcomes

primary outcome

• composite endpoint of TPVI related follow-up events (i.e. death, reoperation, or reintervention \>48h after TPVI)

Time frame: from december 2006 up to December 2027

Secondary Outcomes

secondary measure

TPVI infective endocarditis (I.E.) according to modified Duke criteria n

Time frame: from december 2006 up to December 2027

Central Contacts

Johannes Nordmeyer, Prof

CONTACT

+49 (0) 7071 29-84751 Johannes.Nordmeyer@med.uni-tuebingen.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.